Skip to main content
ORTHOPEDIATRICS CORP logo

ORTHOPEDIATRICS CORP — Investor Relations & Filings

Ticker · KIDS ISIN · US68752L1008 LEI · 5493000KUTPFGOPAT717 US Manufacturing
Open in API
Filings indexed 531 across all filing types
Latest filing 2026-06-04 Declaration of Voting R…
Country US United States of America
Listing US KIDS

About ORTHOPEDIATRICS CORP

https://www.orthopediatrics.com/

OrthoPediatrics Corp. is a medical device company that designs, develops, and commercializes orthopedic implants and instruments exclusively for the pediatric market. The company provides a comprehensive portfolio of products engineered to address the specific anatomical needs of children with orthopedic conditions and injuries. Its offerings serve key categories within pediatric orthopedics, including trauma, deformity correction, and specialty bracing. OrthoPediatrics focuses on providing surgeons with specialized solutions to improve the lives of young patients.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a Form 8-K filed under Item 5.07 “Submission of Matters to a Vote of Security Holders,” detailing vote counts for director elections, advisory compensation votes, plan amendment approval, and auditor appointment. This is a declaration of voting results at the company’s annual meeting. Therefore, it falls under Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-06-04 English
10-Q - ORTHOPEDIATRICS CORP (0001425450) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-01 English
8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
Regulatory Filings
2026-04-30 English
DEF 14A - ORTHOPEDIATRICS CORP (0001425450) (Filer)
Proxy Solicitation & Information Statement
2026-04-20 English
8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes an amendment to a credit agreement, specifically a financing amendment that increases the company's committed financing capacity with a new delayed draw term loan facility. The document includes detailed terms of the financing amendment, such as interest rates, fees, and maturity dates. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is an update on the company's capital structure and financing arrangements. According to the filing definitions, updates on company fundraising, financing activities, or capital structure changes fall under Capital/Financing Update (CAP). The document length is over 6,000 characters and contains substantive detail about the financing amendment, not just a brief announcement or reference to a report. Therefore, the correct classification is CAP with high confidence.
2026-04-01 English
4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
Director's Dealing
2026-03-17 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.